ES2190484T3 - Procedimiento para el diagnostico y la terapia de carcinomas del epitelio plano. - Google Patents
Procedimiento para el diagnostico y la terapia de carcinomas del epitelio plano.Info
- Publication number
- ES2190484T3 ES2190484T3 ES96942362T ES96942362T ES2190484T3 ES 2190484 T3 ES2190484 T3 ES 2190484T3 ES 96942362 T ES96942362 T ES 96942362T ES 96942362 T ES96942362 T ES 96942362T ES 2190484 T3 ES2190484 T3 ES 2190484T3
- Authority
- ES
- Spain
- Prior art keywords
- diagnosis
- procedure
- plano
- carcinomas
- epithelium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCEDIMIENTO PARA DIAGNOSIS Y TRATAMIENTO DE EPITELIOMAS, QUE DESCANSA EN LA EXPRESION DE LA VARIANTE EXON V6 DEL GEN CD44 COMO DIANA MOLECULAR. EN UNA REALIZACION PREFERIDA, PARA ESTE FIN SE UTILIZAN ANTICUERPOS MOLECULARES ESPECIFICOS DE V6, EN PARTICULAR EL ANTICUERPO MONOCLONAL BIWA-1 (VFF-18).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19545472A DE19545472A1 (de) | 1995-12-06 | 1995-12-06 | Verfahren zur Diagnose und Therapie von Plattenepithelkarzinomen |
DE19615074 | 1996-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2190484T3 true ES2190484T3 (es) | 2003-08-01 |
Family
ID=26020988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96942362T Expired - Lifetime ES2190484T3 (es) | 1995-12-06 | 1996-12-05 | Procedimiento para el diagnostico y la terapia de carcinomas del epitelio plano. |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0865609B1 (es) |
JP (1) | JP2000502067A (es) |
KR (1) | KR100473824B1 (es) |
CN (1) | CN1151377C (es) |
AR (1) | AR004360A1 (es) |
AT (1) | ATE235056T1 (es) |
AU (1) | AU726704B2 (es) |
BG (1) | BG62985B1 (es) |
BR (1) | BR9611901A (es) |
CA (1) | CA2239709A1 (es) |
CO (1) | CO4520233A1 (es) |
CZ (1) | CZ174198A3 (es) |
DE (1) | DE59610248D1 (es) |
DK (1) | DK0865609T3 (es) |
EE (1) | EE03783B1 (es) |
ES (1) | ES2190484T3 (es) |
HK (1) | HK1011560A1 (es) |
MX (1) | MX9804459A (es) |
NO (1) | NO319903B1 (es) |
NZ (1) | NZ324314A (es) |
PL (1) | PL184521B1 (es) |
PT (1) | PT865609E (es) |
SK (1) | SK284378B6 (es) |
TR (1) | TR199801027T2 (es) |
UY (1) | UY24389A1 (es) |
WO (1) | WO1997021104A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7189397B2 (en) * | 1999-10-08 | 2007-03-13 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20050100542A1 (en) * | 1999-10-08 | 2005-05-12 | Young David S. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
EE200300569A (et) * | 2001-05-18 | 2004-04-15 | Boehringer Ingelheim International Gmbh | CD44v6-spetsiifilised antikehad |
US20030103985A1 (en) | 2001-05-18 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Cytotoxic CD44 antibody immunoconjugates |
US6972324B2 (en) | 2001-05-18 | 2005-12-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antibodies specific for CD44v6 |
EP1258255A1 (en) * | 2001-05-18 | 2002-11-20 | Boehringer Ingelheim International GmbH | Conjugates of an antibody to CD44 and a maytansinoid |
EP1391213A1 (en) * | 2002-08-21 | 2004-02-25 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
EP1417974A1 (en) * | 2002-11-08 | 2004-05-12 | Boehringer Ingelheim International GmbH | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
CA2786337A1 (en) * | 2010-02-04 | 2011-08-11 | F. Hoffmann-La Roche Ag | A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma |
US9218450B2 (en) * | 2012-11-29 | 2015-12-22 | Roche Molecular Systems, Inc. | Accurate and fast mapping of reads to genome |
JP2021519608A (ja) * | 2018-02-22 | 2021-08-12 | マルティチュード・インコーポレーテッド | 治療抗体およびその使用 |
WO2023227644A2 (en) | 2022-05-25 | 2023-11-30 | Akiram Therapeutics Ab | Binding protein |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995000658A1 (en) * | 1993-06-18 | 1995-01-05 | Sirpa Jalkanen | COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
US6010865A (en) * | 1993-06-22 | 2000-01-04 | Boehringer Ingelheim International Gmbh | Process for detecting a variant CD44 gene product |
DE4326573A1 (de) * | 1993-08-07 | 1995-02-23 | Boehringer Ingelheim Int | Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren |
UA58482C2 (uk) * | 1994-06-08 | 2003-08-15 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти |
-
1996
- 1996-12-03 UY UY24389A patent/UY24389A1/es not_active IP Right Cessation
- 1996-12-04 AR ARP960105480A patent/AR004360A1/es unknown
- 1996-12-05 PT PT96942362T patent/PT865609E/pt unknown
- 1996-12-05 NZ NZ324314A patent/NZ324314A/en unknown
- 1996-12-05 JP JP9520993A patent/JP2000502067A/ja not_active Ceased
- 1996-12-05 CZ CZ981741A patent/CZ174198A3/cs unknown
- 1996-12-05 EE EE9800164A patent/EE03783B1/xx not_active IP Right Cessation
- 1996-12-05 ES ES96942362T patent/ES2190484T3/es not_active Expired - Lifetime
- 1996-12-05 WO PCT/EP1996/005448 patent/WO1997021104A1/de not_active Application Discontinuation
- 1996-12-05 CA CA002239709A patent/CA2239709A1/en not_active Abandoned
- 1996-12-05 AU AU11773/97A patent/AU726704B2/en not_active Ceased
- 1996-12-05 BR BR9611901A patent/BR9611901A/pt not_active Application Discontinuation
- 1996-12-05 SK SK736-98A patent/SK284378B6/sk unknown
- 1996-12-05 DE DE59610248T patent/DE59610248D1/de not_active Expired - Fee Related
- 1996-12-05 KR KR10-1998-0704242A patent/KR100473824B1/ko not_active IP Right Cessation
- 1996-12-05 EP EP96942362A patent/EP0865609B1/de not_active Expired - Lifetime
- 1996-12-05 CN CNB961992484A patent/CN1151377C/zh not_active Expired - Fee Related
- 1996-12-05 AT AT96942362T patent/ATE235056T1/de not_active IP Right Cessation
- 1996-12-05 CO CO96063967A patent/CO4520233A1/es unknown
- 1996-12-05 DK DK96942362T patent/DK0865609T3/da active
- 1996-12-05 TR TR1998/01027T patent/TR199801027T2/xx unknown
- 1996-12-05 PL PL96327066A patent/PL184521B1/pl not_active IP Right Cessation
-
1998
- 1998-06-04 MX MX9804459A patent/MX9804459A/es not_active IP Right Cessation
- 1998-06-05 BG BG102513A patent/BG62985B1/bg unknown
- 1998-06-05 NO NO19982588A patent/NO319903B1/no unknown
- 1998-12-07 HK HK98112910A patent/HK1011560A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0865609B1 (de) | 2003-03-19 |
AU1177397A (en) | 1997-06-27 |
DE59610248D1 (de) | 2003-04-24 |
SK284378B6 (sk) | 2005-02-04 |
MX9804459A (es) | 1998-09-30 |
EE03783B1 (et) | 2002-06-17 |
NO982588D0 (no) | 1998-06-05 |
PL327066A1 (en) | 1998-11-23 |
JP2000502067A (ja) | 2000-02-22 |
CO4520233A1 (es) | 1997-10-15 |
EP0865609A1 (de) | 1998-09-23 |
CN1151377C (zh) | 2004-05-26 |
NO982588L (no) | 1998-08-05 |
CZ174198A3 (cs) | 1999-02-17 |
KR19990071952A (ko) | 1999-09-27 |
PT865609E (pt) | 2003-08-29 |
HK1011560A1 (en) | 1999-07-16 |
CA2239709A1 (en) | 1997-06-12 |
UY24389A1 (es) | 2001-10-25 |
AU726704B2 (en) | 2000-11-16 |
CN1207811A (zh) | 1999-02-10 |
EE9800164A (et) | 1998-12-15 |
NZ324314A (en) | 2000-02-28 |
KR100473824B1 (ko) | 2005-09-30 |
WO1997021104A1 (de) | 1997-06-12 |
BR9611901A (pt) | 1999-03-02 |
BG102513A (en) | 1999-02-26 |
BG62985B1 (bg) | 2000-12-29 |
ATE235056T1 (de) | 2003-04-15 |
AR004360A1 (es) | 1998-11-04 |
PL184521B1 (pl) | 2002-11-29 |
TR199801027T2 (xx) | 1998-10-21 |
DK0865609T3 (da) | 2003-06-23 |
SK73698A3 (en) | 1999-01-11 |
NO319903B1 (no) | 2005-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2190484T3 (es) | Procedimiento para el diagnostico y la terapia de carcinomas del epitelio plano. | |
CY1108765T1 (el) | ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2 | |
CY1112458T1 (el) | Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου | |
CY1117764T1 (el) | Χιμαιρικα υβριδια μονομερους-διμερους ανοσοσφαιρινης | |
PE20050712A1 (es) | Anticuerpos rg1 | |
SE7512192L (sv) | Cancerantigen, cancerterapi och cancerdiagnostikum | |
ES2184866T3 (es) | Composicion de tampon para reactivos de dosificado inmunologico. | |
DE69129302T2 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
MY154009A (en) | Anti-alpha v beta 6 antibodies | |
ATE197592T1 (de) | Monoklonaler antikörper gegen cd44v6 | |
DE69006135T2 (de) | Einsatzrohr für die Reparatur von Rohrleitungen. | |
ES2074062T3 (es) | Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda. | |
DK261386A (da) | Monoklonale antistoffer | |
BR0015622A (pt) | Processo de limpeza que utiliza ondas ultra-sÈnicas | |
DK121683A (da) | Fremgangsmaade til fremstilling af immunoenzymatiske konjugater | |
DE60331638D1 (de) | Keratin-netzwerke enthaltende wundverbände für gewebedefekte | |
ATE364396T1 (de) | Behandlung von pilzinfektion mit polyenen oder beta glucan synthese hemmern kombiniert mit anti- hsp antikörpern | |
NO965395L (no) | Humane, monoklonale antistoffer som er spesifikke mot cellecyklus-uavhengig gliom-overflateantigen | |
ES2062809T3 (es) | Proteinas bacterianas del estres. | |
CO4940435A1 (es) | Sal de hemisulfato del (1s,4r)-cis-4-[2-amino-6- (ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol o un solvato del mismo | |
BR0314716A (pt) | Anticorpos de subunidade alfa de lfa-1 e métodos de uso | |
DK1173766T3 (da) | Isoform af tenascin-C som markör for neoplasier | |
UY26266A1 (es) | Antigeno asociado con tumores (r11) ley 17164 | |
ES2073531T3 (es) | Produccion de oxido de propileno. | |
FI974018A0 (fi) | Ihmisen 2 integriini -alayksikkö |